Sonnet BioTherapeutics Announces $888M Combination With Rorschach For HYPE Treasury

Sonnet BioTherapeutics (NASDAQ: SONN) announced a transformative $888 million business combination with Rorschach I LLC to form Hyperliquid Strategies Inc. (HSI), pivoting from biotech to a cryptocurrency treasury strategy focused on HYPE tokens. The new entity will hold 12.6 million HYPE tokens (valued at ~$583 million) and $305 million in cash, aiming to be the [...]The post Sonnet BioTherapeutics Announces $888M Combination With Rorschach For HYPE Treasury appeared first on Tekedia.

Read More